Tiospirone

N/A

Report date: 2022/05/25 17:50:39
NME

Base Information

Drug NameTiospirone
Drug Alias Name替螺酮BMY-13859
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMead Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMead Johnson & Company Llc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG